With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...

Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt ...

In the broader markets, the Nifty Midcap 100 climbed 0.51 per cent and the Nifty Smallcap 100 was higher by 0.42 per cent ...

Norepinephrine bitartrate injection is a critical medication used to raise blood pressure in adult patients suffering from ...

While medications provide temporary weight-loss solutions, experts stress lifestyle changes as the most effective way to ...

PD-1, PD-L1, and VEGF inhibitors have been approved for over 50 indications in addition to NSCLC. Summit CEO Maky Zanganeh ...

Biocon added 1.34% to Rs 348.55 after the company's wholly owned subsidiary Biocon Pharma announced the receipt of U.S Food and Drug Administration (US FDA) approval for its ANDA Norepinephrine ...

Glucagon-like peptide-1 (GLP-1) and Gastric inhibitory polypeptide (GIP) while Ozempic (Semaglutide) only targets GLP-1.

The Ensuring Pathways to Innovative Cures Act would extend the time Medicare can negotiate and set prices for small molecule ...

The Jordan Food and Drug Administration (JFDA) has approved registration of 90 medicines, aimed to achieve Jordan's drug security, in accordance with the 2024 Special Drug Registration Instructions.

Harvey Jones has spotted signs of life in the GSK share price. Which is a relief after its recent troubles, so can the FTSE ...

As market participants await the onset of the monthly F&O expiry week with the opening bell on March 24, here are a number of ...